Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 31, 2011. The report details a specific share repurchase transaction executed in accordance with shareholder authority granted at the Annual General Meeting on May 6, 2010.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 425,000 Ordinary shares of 25 pence each.
- Purchase Date: March 31, 2011.
- Price Range: Highest price paid was 1,202.5 pence per share; lowest price paid was 1,190.5 pence per share.
- Treasury Holdings: 493,224,284 shares held in Treasury.
- Treasury Percentage: Represents 8.71% of total issued share capital and 9.54% of total voting rights.
- Shares in Issue: 5,171,221,373 shares (excluding Treasury shares).
Material Changes
The primary material change reported is the reduction of outstanding share capital through the cancellation of 425,000 repurchased shares. The filing does not provide comparative data against prior periods for financial performance or other operational metrics.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies. It is a compliance disclosure confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer to purchase securities.
Key Facts for Investor Verification
- Verify the total cost of the 425,000 share repurchase based on the disclosed price range (1,190.5 to 1,202.5 pence).
- Confirm the impact of the 8.71% Treasury share holding on earnings per share calculations.
- Check subsequent filings for the full Q1 2011 financial results, as this document does not contain revenue or profit data.
- Validate the total voting rights denominator (5,171,221,373 shares) for disclosure threshold calculations.